Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine vs Hydrochlorothiazide in OSA Hypertension
NCT02699125Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Jan 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of guanfacine in hypertension (HTN), sponsored by University of California, San Diego. Primary endpoints: 24-h, Wake and Sleep Period Systolic Blood Pressure and 24-h, Wake and Sleep Period Diastolic Blood Pressure. Started Jan 2015; status: completed.
02
Drugs
guanfacine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02699125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02699125.